1. Liu, Xi, Zhuang, Haihui, Li, Fenglin, Lu, Ying, Pei, Renzhi. 2024. Prognostic Significance of Dual-Specificity Phosphatase 23 Expression in Acute Myeloid Leukemia. In Journal of blood medicine, 15, 35-50. doi:10.2147/JBM.S437400. https://pubmed.ncbi.nlm.nih.gov/38344181/
2. Keum, Seula, Lee, Yoon Ji, Kim, Jung-Woong, Rhee, Sangmyung. 2024. Dual-specificity phosphatase 23 functions as a promising prognostic biomarker in non-small cell lung cancer. In Genes & genomics, , . doi:10.1007/s13258-024-01604-9. https://pubmed.ncbi.nlm.nih.gov/39693003/
3. Balada, E, Felip, L, Ordi-Ros, J, Vilardell-Tarrés, M. 2016. DUSP23 is over-expressed and linked to the expression of DNMTs in CD4+ T cells from systemic lupus erythematosus patients. In Clinical and experimental immunology, 187, 242-250. doi:10.1111/cei.12883. https://pubmed.ncbi.nlm.nih.gov/27737517/
4. Xu, Zhiqiang, Yu, Jieni, Chen, Yamei. 2024. Hub genes and associated drugs for multiple myeloma with 1q21+: identified by bioinformatic analysis. In Hematology (Amsterdam, Netherlands), 29, 2323890. doi:10.1080/16078454.2024.2323890. https://pubmed.ncbi.nlm.nih.gov/38433435/
5. Chuang, Huai-Chia, Tan, Tse-Hua. 2019. MAP4K Family Kinases and DUSP Family Phosphatases in T-Cell Signaling and Systemic Lupus Erythematosus. In Cells, 8, . doi:10.3390/cells8111433. https://pubmed.ncbi.nlm.nih.gov/31766293/